FINWIRES · TerminalLIVE
FINWIRES

三井不動産アコモデーションファンドの6ヶ月間の純利益は8.6%増加

By

-- 三井不動産アコモデーションファンド投資法人(TKO:3226)の2月28日までの6ヶ月間の純利益は、前年同期の58億5000万円から8.6%増加し、63億5000万円となった。

同REITの1口当たり純利益は、前年同期の2324円から2523円に増加した。

総収入は、前年同期の132億円から4%増加し、137億円となった。

同REITは、1口当たり2405円の期末分配金を5月15日から支払うことを決定した。

8月31日までの会計年度について、同REITは純利益67億円、総収入146億円を見込んでいる。

2027年2月28日までの6ヶ月間において、当REITは純利益60億円、総収益138億円を見込んでいる。

三井不動産は、2026年8月期に1口当たり2,397円、2027年2月期に1口当たり2,384円の分配金を支払う。

Related Articles

Asia

Dongjiang Environmental's Loss Widens 2.7% in Q1

Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.

$HKG:0895$SHE:002672
Sectors

Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday

Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.

$IBB$LGND$OGN$ORKA$XLV$XOMA
Asia

Zuoli Kechuang Logs Drop in Q1 Profit

Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.

$HKG:6866